Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream

Health and medicine

Home » Health and medicine

Nature Publishing Group Study Highlights Potential of Indee Labs Technology as an Alternative to Current Gene-Modified Cell Therapy Manufacturing

Microfluidic method could speed up life-saving chimeric antigen receptor T cell (CAR-T) treatments for advanced cancer patients and solve the scalability challenges March 19, 2019 08:00 AM Eastern Daylight Time –...

Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease

Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines

Cambridge, Mass. – Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the successful completion of a $135 million Series B financing. Proceeds from...